Literature DB >> 3932193

The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.

O Kildahl-Andersen, J Nissen-Meyer.   

Abstract

The role of monocyte cytotoxic factor (CF) in cytostasis mediated by lymphokine- and interferon gamma (IFN-gamma)-activated monocytes was investigated. Recombinant IFN-gamma as well as lymphokines enhanced monocyte-mediated cytostasis concomitantly with an increase in monocyte CF content. The incubation of lymphokines with monoclonal antibody against human IFN-gamma inhibited cytostasis mediated by lymphokine-exposed monocytes, indicating that the main monocyte-activating factor in the lymphokine supernatant was IFN-gamma. A neutralizing antiserum raised against purified CF inhibited monocyte-mediated cytostasis in a dose-dependent manner. When CF antiserum was added to monocytes previously exposed to lymphokines treated with a monoclonal antibody against IFN-gamma, all cytostatic activity was completely abrogated. No inhibitory effect on cytostasis was observed with preimmune serum. The results indicate that CF is an effector molecule in cytostasis mediated by lymphokine- or IFN-gamma-activated monocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932193      PMCID: PMC1453681     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Sensitivity to macrophage-mediated cytostasis is cell cycle dependent.

Authors:  T A Hamilton; M Fishman; G Crawford; A T Look
Journal:  Cell Immunol       Date:  1982-05-15       Impact factor: 4.868

3.  Production of an anti-tumour cytotoxin by human monocytes.

Authors:  N Matthews
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

4.  Soluble cytostatic factor(s) released from human monocytes. I. Production and effect on normal and transformed human target cells.

Authors:  J Hammestrøm
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

5.  Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.

Authors:  D J Cameron; W H Churchill
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Physicochemical characterization of cytostatic factors released from human monocytes.

Authors:  J Nissen-Meyer; J Hammerstrøm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptide.

Authors:  O Kildahl-Andersen; J Nissen-Meyer
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

8.  Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.

Authors:  J Hammerstrøm
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

9.  Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin.

Authors:  N Matthews
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

10.  Human monocyte mediated cytotoxicity to K-562 cells: a freeze-fracture-, scanning- and thin section electron microscopic study.

Authors:  T Espevik; J Hammerstrøm; J Halgunset
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-06
View more
  4 in total

1.  WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysis.

Authors:  O Kildahl-Andersen; R Austgulen; J Nissen-Meyer
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.

Authors:  R Austgulen; O Kildahl-Andersen; T Espevik
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF.

Authors:  Y Ichinose; J Y Tsao; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro.

Authors:  S J Brett; R Butler
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.